Imagine being diagnosed with eye cancer – but your doctor can’t tell whether you have the aggressive type that will swiftly spread, causing blindness and death in as early as a year. A new procedure at UCLA’s Jules Stein Eye Institute could reveal this valuable information to ocular melanoma patients and their physicians, providing a clear basis for making treatment and lifestyle choices. Researchers have pioneered the first technique to biopsy tissue from the living eye in order to predict which tumors possess high metastatic risk. The Nov. 15 online edition of the journal Ophthalmology reports the findings, which urge a new treatment strategy for physicians and offer huge medical and psychological benefits to patients. >>> Discuss This Story
